Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells
Shimizu, J.; Suda, T.; Yoshioka, T.; Kosugi, A.; Fujiwara, H.; Hamaoka, T.
The Journal of Immunology (1950) 142(3): 1053-1059
1989
ISSN/ISBN: 0022-1767
Accession: 075897040
PDF emailed within 1 workday: $29.90
Related References
Hamaoka, T.; Shimizu, J.; Suda, T.; Fujiwara, H. 1988: Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells Princess Takamatsu Symposia 19: 265-275Shimizu, J.; Suda, T.; Yoshioka, T.; Kosugi, A.; Fujiwara, H.; Hamaoka, T. 1989: Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells Journal of Immunology 142(3): 1053-1059
Mukherji, B.; Chakraborty, N.G.; Yamasaki, S.; Okino, T.; Yamase, H.; Sporn, J.R.; Kurtzman, S.K.; Ergin, M.T.; Ozols, J.; Meehan, J. 1995: Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells Proceedings of the National Academy of Sciences of the United States of America 92(17): 8078-8082
Celluzzi, C.M.; Mayordomo, J.I.; Storkus, W.J.; Lotze, M.T.; Falo, L.D. 1996: Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity Journal of Experimental Medicine 183(1): 283-287
Saha, A.; Chatterjee, S.K.; Foon, K.A.; Primus, F.J.; Bhattacharya Chatterjee, M. 2003: Dendritic cells pulsed with an anti-idiotype antibody can induce antigen-specific CTL-mediated protective anti-tumor immunity in a murine tumor model transduced with human CEA FASEB Journal 17(7): C328
Chang, H-Cai.; Zou, Z-Zhi.; Wang, Q-Hong.; Li, J.; Jin, H.; Yin, Q-Xia.; Xing, D. 2020: Targeting and Specific Activation of Antigen-Presenting Cells by Endogenous Antigen-Loaded Nanoparticles Elicits Tumor-Specific Immunity Advanced Science 7(1): 1900069
Xie, Y.C.; Hwang, C.; Overwijk, W.; Zeng, Z.; Eng, M.H.; Mulé, J.J.; Imperiale, M.J.; Restifo, N.P.; Sanda, M.G. 1999: Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen Journal of the National Cancer Institute 91(2): 169-175
Santin, A.D.; Hermonat, P.L.; Ravaggi, A.; Bellone, S.; Pecorelli, S.; Cannon, M.J.; Parham, G.P. 2000: In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer American Journal of Obstetrics and Gynecology 183(3): 601-609
Peshwa, M.V.; Shi, J.D.; Ruegg, C.; Laus, R.; van Schooten, W.C. 1998: Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide Prostate 36(2): 129-138
Kim, T.S.; Chung, S.W.; Kim, S.H.; Kang, B.Y.; Hwang, S.Y.; Lee, J.W. 2000: Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo Cancer Gene Therapy 7(6): 861-869
Tüting, T.; Gambotto, A.; DeLeo, A.; Lotze, M.T.; Robbins, P.D.; Storkus, W.J. 1999: Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice Cancer Gene Therapy 6(1): 73-80
Mocikat, R.; Lindhofer, H. 2001: Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells Official Gazette of the United States Patent and Trademark Office Patents 1252(4)
Takahara, M.; Miyai, M.; Tomiyama, M.; Mutou, M.; Nicol, A.J.; Nieda, M. 2008: Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation Journal of Leukocyte Biology 83(3): 742-754
Zou, J.P.; Shimizu, J.; Ikegame, K.; Takiuchi, H.; Fujiwara, H.; Hamaoka, T. 1992: Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells Cancer Immunology Immunotherapy: Cii 35(1): 1-6
Protti, M.P.; De Monte, L.; Monte, L.D.; Di Lullo, G.; Lullo, G.D. 2014: Tumor antigen-specific CD4+ T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies Tissue Antigens 83(4): 237-246